The new corona virus SARS-CoV-2 has been raging since January 2020, spreading at an unprecedented pace, exhibiting insidious properties and puzzling experts. SCHURTER has taken this fact into account and has ramped up the production of its medical products.
Thanks to decades of expertise in manufacturing as a supplier of medical technology, SCHURTER was able to avert the lockdown of many of its production facilities. Pandemic and system-relevant plants were closed in very few countries.
SCHURTER took advantage of this situation and decided to drastically increase its capacities in favour of the production of components and input systems for medical technology.
This acquisition further establishes Quantum Machines as the quantum company with the broadest global footprint,…
Supporting planned growth in InP silicon photonics technology Resolving all prior IP disputes between the…
Norwest leads the round with strategic participation from Snowflake Ventures, as Jedify addresses the AI…
Round brings total funding to $15 million from U.S., European and Israeli investors to support…
Quantum Machines achieves 99.5% median two-qubit gate fidelity when operating Rigetti Computing’s Novera™ superconducting QPU…
Unframe, the managed AI delivery platform for global enterprises, today announced it has crossed $100…
